No photo of Emmanuel Antonarakis

View Scopus Profile

Emmanuel Antonarakis

ASSOCIATE PROFESSOR

20022018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 14 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Castration Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Androgen Receptors Medicine & Life Sciences
Androgens Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2018

Abiraterone plus olaparib in prostate cancer: a new form of synthetic lethality?

Antonarakis, E. S., Jan 1 2018, (Accepted/In press) In : The Lancet Oncology.

Research output: Contribution to journal › Article

Prostatic Neoplasms
Synthetic Lethal Mutations
abiraterone
olaparib

AR signaling in humanmalignancies: Prostate cancer and beyond

Antonarakis, E. S. Jan 18 2018 In : Cancers. 10, 1, 22

Research output: Contribution to journal › Editorial

Androgen Receptors
Prostatic Neoplasms
Salivary Gland Neoplasms
Androgen Antagonists
Urinary Bladder Neoplasms

Circulating tumor cell eradication as an intermediate efficacy end point for metastatic castration-resistant prostate cancer: Is there enough evidence?

Antonarakis, E. S., Feb 20 2018, In : Journal of Clinical Oncology. 36, 6, p. 525-527 3 p.

Research output: Contribution to journal › Editorial

Circulating Neoplastic Cells
Castration
Prostatic Neoplasms

Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies

Sfanos, K. S., Markowski, M. C., Peiffer, L. B., Ernst, S. E., White, J. R., Pienta, K. J., Antonarakis, E. S. & Ross, A. E., Jul 9 2018, (Accepted/In press) In : Prostate Cancer and Prostatic Diseases. p. 1-10 10 p.

Research output: Contribution to journal › Article

Androgens
Prostatic Neoplasms
Therapeutics
Microbiota
Immunotherapy

Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer

Haffner, M. C. , Guner, G. , Taheri, D. , Netto, G. J. , Palsgrove, D. N. , Zheng, Q. , Guedes, L. B. , Kim, K. , Tsai, H. , Esopi, D. M. , Lotan, T. L. , Sharma, R. , Meeker, A. K. , Chinnaiyan, A. M. , Nelson, W. G. , Yegnasubramanian, S. , Luo, J. , Mehra, R. , Antonarakis, E. S. , Drake, C. G. & 1 others De Marzo, A. M., Jun 1 2018, In : American Journal of Pathology. 188, 6, p. 1478-1485 8 p.

Research output: Contribution to journal › Article

Prostatic Neoplasms
Ligands
Programmed Cell Death 1 Receptor
Adenocarcinoma
Small Cell Carcinoma